Lil’ Turtles is recalling Grandma Belle’s Tomato Basil Soup due to a milk allergen not being listed on the label.
Newsweek reached out to the company via phone for comment.
According to the FDA alert, all lot numbers of the soup product are impacted in the recall. The product was packaged in 17-ounce glass jars and was available in retail stores from September 23, 2022, to December 3, 2025.
The jars were sold in certain retail stores in Ohio, Pennsylvania, New York, Kentucky, Minnesota, Utah, Oklahoma, Kansas, Mississippi, Illinois, Indiana, Missouri, Wisconsin, and Iowa. The FDA alert lists the specific stores affected.
Below is a map of the states affected by the recall:
“The issue was discovered during a routine inspection conducted by the Ohio Department of Agriculture,” the alert says. “There have been no reports of illness involving the product addressed in this recall, however, people who have an allergy or severe sensitivity to milk run the risk of a serious allergic reaction if they consume this product.”
Customers who have purchased the recalled soup and have a sensitivity or allergy to milk are urged to contact Lil’ Turtles for a new pack, the alert says. People with additional questions about the recall may contact the company at 330-897-6400.
Numerous public health alerts and recalls have been issued this year due to potential damage, foodborne illness, contamination and undeclared food allergens.
Millions of Americans experience food sensitivities or allergies every year. According to the U.S. Food and Drug Administration (FDA), the nine “major” food allergens in the United States are eggs, milk, fish, wheat, soybeans, crustacean shellfish, sesame, tree nuts and peanuts.
The FDA told Newsweek in January that “most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall, the FDA shares that release on our website as a public service.
“The FDA’s role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall.”
It added: “The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled.”
Additional information on recalls can be found on the FDA’s Recalls, Market Withdrawals, & Safety Alerts page.
